Drugs Made In America Acquisition II Corp.

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

FY: Dec 31 2025

Q: Sep 30 2025

Q: Sep 30 2025

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Other Events

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Other Events

Entry into a Material Definitive Agreement

Prospectus Supplement with Pricing Information

Registration of Securities on Exchange

Certification of approval for listing and registration on a national securities exchange

Notice of Effectiveness

Amended Initial Registration Statement

Amended Initial Registration Statement

Amended Initial Registration Statement

Registration (IPO) statement under Securities Act of 1933

Do Catherine

Drugs Made In America Acquisition II LLC

Shulgan Myron W.

Drugs Made In America Acquisition II LLC

Stockwell Lynn

Prasad Sridhar G.

Worman Glenn C.

Drugs Made In America Acquisition II LLC

Shulgan Myron W.

Worman Glenn C.

Stockwell Lynn

Prasad Sridhar G.

Do Catherine

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Draft registration statement (confidential submission) (amendment)

No description available

Letter from the SEC

Draft registration statement (confidential submission)